Menu
Sign In Pricing Add Podcast

Acquired

Novo Nordisk (Ozempic)

7682.161 - 7702.93 David Rosenthal

This is annual recurring revenue here. Yeah. So in early 2010, Novo gets final approval for Victoza, which is the marketing name for the diabetes version of liraglutide. So five years after Bayeta, Victoza is finally officially hitting the market in the U.S. And remember, this is just FDA approved for diabetes.

0
💬 0

Comments

There are no comments yet.

Log in to comment.